LTRN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lantern Pharma Inc (LTRN) is not a strong buy at the moment for a beginner, long-term investor. The lack of significant trading trends, poor financial performance, absence of positive news catalysts, and no strong technical or proprietary trading signals suggest that the stock does not currently present a compelling investment opportunity. Given the user's preference for long-term investment, it would be prudent to wait for stronger financial growth or positive catalysts before considering this stock.
The MACD is slightly positive at 0.0281, indicating mild bullish momentum, but it is contracting. RSI is neutral at 47.188, showing no clear overbought or oversold conditions. Moving averages are converging, indicating indecision in price direction. Key support is at 2.509, and resistance is at 2.998. The stock is trading near its pivot point of 2.754, suggesting limited immediate upside potential.
NULL identified. No recent news or significant trading activity from hedge funds, insiders, or congress. No proprietary trading signals or analyst upgrades.
No recent news or events to drive positive sentiment. Stock trend analysis indicates a higher probability of negative returns in the next month (-2.33%).
In Q3 2025, the company reported no revenue growth (0% YoY), a net income decline of -7.29% YoY to -$4,177,423, and an EPS drop of -7.14% YoY to -0.39. Gross margin remains at 0%. These metrics indicate poor financial health and lack of growth.
No recent analyst ratings or price target changes available. No Wall Street sentiment data provided.
